These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2576958)

  • 1. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
    Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A
    Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma.
    Troncone L; Rufini V; De Rosa G; Testa A
    Henry Ford Hosp Med J; 1989; 37(3-4):178-84. PubMed ID: 2576959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
    Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
    J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
    Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
    J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
    Celentano L; Sullo P; Klain M; Lupoli G; Cascone E; Salvatore M
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
    Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
    J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience in imaging medullary thyroid carcinoma using 99mTc (V) dimercaptosuccinic acid (DMSA).
    Clarke S; Lazarus C; Maisey M
    Henry Ford Hosp Med J; 1989; 37(3-4):167-8. PubMed ID: 2576956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New tracers for the imaging of the medullary thyroid carcinoma.
    Guerra UP; Pizzocaro C; Terzi A; Giubbini R; Maira G; Pagliaini R; Bestagno M
    Nucl Med Commun; 1989 Apr; 10(4):285-95. PubMed ID: 2544835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors.
    Limouris GS; Giannakopoulos V; Stavraka A; Toubanakis N; Vlahos L
    Anticancer Res; 1997; 17(3B):1589-92. PubMed ID: 9179199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor.
    Rufini V; Salvatori M; Saletnich I; Valenza V; Maussier ML; Martino G; Corsello SM; Pantusa M; Casolo A; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):140-4. PubMed ID: 9002774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
    Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
    Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphic detection of recurrence of medullary thyroid cancer.
    Koizumi M; Yamada Y; Nomura E; Amano M; Okajima Y; Okizuka H; Yamada K; Sawano S; Kitahara T; Yamashita T
    Ann Nucl Med; 1995 May; 9(2):101-4. PubMed ID: 7662489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas?
    Becker W; Börner W; Reiners C
    Horm Metab Res Suppl; 1989; 21():38-42. PubMed ID: 2553574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medullary carcinoma of the thyroid: management of persistent hypercalcitonaemia utilizing [99mTc] (v) dimercaptosuccinic acid scintigraphy.
    Udelsman R; Mojiminiyi OA; Soper ND; Buley ID; Shepstone BJ; Dudley NE
    Br J Surg; 1989 Dec; 76(12):1278-81. PubMed ID: 2557953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MTC).
    Guerra U; Pizzocaro C; Terzi A; Giubbini R; Bestagno M
    J Nucl Med Allied Sci; 1988; 32(4):242-7. PubMed ID: 2852709
    [No Abstract]   [Full Text] [Related]  

  • 17. [The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)].
    Ahuja S; Koppenhagen K; Ernst H
    Strahlenther Onkol; 1990 Nov; 166(11):718-21. PubMed ID: 2260009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medullary carcinoma of the thyroid and 99mTc(V)-DMSA scintigraphy. Clinical results with a new radiopharmaceutical].
    Kujat C; Neidl K; Müller-Leisse C
    Rofo; 1990 Nov; 153(5):495-500. PubMed ID: 2173051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals].
    Tada J; Konishi J; Torizuka K; Makimoto K; Miyauchi A
    Rinsho Hoshasen; 1984 Sep; 29(9):1043-4. PubMed ID: 6096600
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus C; Mistry R; Maisey MN
    Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.